1. Japan Stocks

  2. •

    Retail trade

  3. •

    Drugstore chains
Medical Ikkou Group Co., Ltd.

Medical Ikkou Group Co., Ltd.

TTSE:3353
2,770.00
JPY
-3.00
(-0.11%)
356.59EPS
7.25P/E
9.47BMarket Cap
Jan 13Next Earn
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
2026 Y
TTM
Revenue per Share
5,968.78
6,885.73
7,647.32
7,695.3
8,067.23
8,158.25
8,404.87
8,376.48
8,944.48
9,023.37
10,618.43
12,869.66
14,606.64
12,003.44
Basic EPS, GAAP
178.94
208.1
237.62
249.48
323.12
185.95
210.37
221.31
226.92
202.2
276.71
301.35
338.74
347.18
Free Cash Flow per Basic Share
-12.47
-129.06
183.25
53.45
255.51
-152.21
352.02
353.64
212.46
255.58
1,052.06
43.32
174.33
- -
Dividend per Share
25
43.75
35
36
40
40.05
40
42.65
40
40
40
50
100
- -
Book Value per Share
1,490.81
1,666.1
1,891.79
2,112.5
2,427.01
2,505.51
2,667.88
2,791.36
3,030.61
3,207.15
3,523.26
3,747.71
4,164.98
3,662.09
Tangible Book Value per Share
1,182.55
1,347.66
1,586.93
1,754.15
2,133.11
2,093.53
2,307.61
2,273.06
2,574.44
2,813.5
3,294.34
3,484.64
3,916.09
3,382.7
Basic Weighted Avg Shares
4
4
4
4
4
4
4
4
4
4
4
4
4
4
Sales/Revenue/Turnover
22,874
26,387
29,306
29,490
30,915
31,222
32,042
31,604
33,596
33,898
39,901
48,393
54,983
45,116
Operating Margin (%)
5.5
4.81
4.87
4.07
4.55
3.34
3.76
3.25
3.8
2.76
3.91
3.5
3.25
3.96
Depreciation Expense
485
674
736
760
786
849
826
838
870
842
784
763
844
- -
Net Income, GAAP
686
797
911
956
1,238
712
802
835
852
760
1,040
1,133
1,275
1,305
Effective Tax Rate (%)
43.91
41.83
41.56
38.95
36.16
39.07
36.99
42.08
41.12
41.14
34.95
39.68
35.08
33.76
Profit Margin (%)
3
3.02
3.11
3.24
4.01
2.28
2.5
2.64
2.54
2.24
2.61
2.34
2.32
2.89
Working Capital
1,869
1,987
2,448
2,588
2,891
3,509
4,184
4,557
6,161
5,785
6,319
6,296
7,529
6,567
LT Debt
5,402
7,626
7,954
8,020
6,665
7,430
7,043
7,857
7,580
6,253
5,884
6,228
7,553
5,898
Total Equity
5,713
6,385
7,250
8,095
9,301
9,552
10,171
10,485
11,928
12,608
13,841
14,712
16,339
14,394
Return on Invested Capital (%)
5.64
4.89
4.65
3.77
4.48
3.1
3.65
2.74
3.25
2.42
4.44
4.16
4.44
5.08
Return on Capital (%)
5.95
5.75
5.5
5.29
6.55
3.72
4.09
4.06
3.82
3.45
4.58
4.81
5.06
5.7
Return on Common Equity (%)
12.77
13.18
13.36
12.46
14.24
7.55
8.13
8.08
7.8
6.48
8.22
8.29
8.56
9.93

Capital Structure

JPY

•

in mil. unless spec.
Feb'24
May'25
Aug'25
ST Debt
3,695
3,404
3,464
LT Borrowings
5,717
5,352
5,721
LT Finance Leases
167
183
177
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
4
4
4
Market Capitalization
8,775
9,621
9,472

Working Capital

JPY

•

in mil. unless spec.
Feb'24
May'25
Aug'25
Total Current Assets
16,723
16,408
17,844
Cash, Cash Equivalents & STI
7,700
6,879
8,191
Accounts Receivable, Net
6,060
6,261
6,668
Inventories
1,753
1,756
1,789
Total Current Liabilities
10,404
10,526
11,277
Payables & Accruals
- -
- -
- -
ST Debt
3,695
3,404
3,464
Deferred Revenue
- -
- -
- -

Growth Rates

JPY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
8.54%
9.32%
11.05%
Free Cash Flow
31.56%
99.76%
302.8%
Net Income, GAAP
5.84%
9.92%
12.52%
Sales/Revenue/Turnover
6.75%
11.96%
13.62%
Total Cash Common Dividend
- -
23.74%
100.23%

Quarterly Revenue

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
8,722
8,729
11,319
11,131
39,901
2025
11,184
11,482
- -
- -
48,393
2026
- -
- -
- -
- -
54,983

Quarterly Earnings Per Share

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
56.42
61.84
97.94
60.5
276.71
2025
114.24
74.52
- -
- -
301.35
2026
- -
- -
- -
- -
338.74

Quarterly Dividends Per Share

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
40
2025
- -
- -
- -
- -
50
2026
- -
- -
- -
- -
100

Company Description

Company Profile APIChatGPT
CEO
Toshihisa Minamino
Full Time Employees
1,608
Sector
Retail trade
Industry
Drugstore chains
Address
No. 36-25, Nishimarunouchi Tsu MI Japan 514-0035
IPO Date
Nov 26, 2004
Website
m-ikkou.co.jp
Similar Companies
CVS Health Corporation (NYSE:CVS)
MatsukiyoCocokara & Co. (TSE:3088)
Guardian Pharmacy Services, Inc. (NYSE:GRDN)
TSURUHA Holdings, Inc. (TSE:3391)
MedPlus Health Services Ltd. (NSE:MEDPLUS)
Raia Drogasil S.A. (B3:RADL3)
Business
Medical Ikkou Group Co., Ltd. Medical Ikkou Group Co., Ltd. (3353.T) is a Japan-based healthcare services provider primarily engaged in the operation of dispensing pharmacies that fill prescriptions issued by medical institutions, alongside nursing care, pharmaceutical wholesale, real estate leasing, and investment activities. The company operates through four main business segments: the dispensing pharmacy segment, which includes 98 pharmacies and 22 sales offices across regions centered on Mie Prefecture in the Kansai and Hokuriku areas, with expansions into Kanto including Kanagawa and Yamanashi; the healthcare segment encompassing 55 facilities such as 42 residential care homes including paid nursing homes and group homes, 22 day service offices, and 6 home-visit care offices, along with leasing of medical facilities, welfare equipment rentals, and related medical-nursing services; the medicine wholesale segment focused on distributing generic drugs and pharmaceutical products to medical institutions; and the real estate segment involving leasing of hotels, hospitals, and other properties, complemented by investments in listed and unlisted stocks and M&A opportunities. Founded in 1985 and headquartered in Tsu-shi, Mie-ken, with a Tokyo branch in Minato-ku, the company employs 2,557 people including 496 pharmacists group-wide as of June 2025, and serves target markets in Japan emphasizing elderly care amid aging demographics and generic drug promotion policies. Recent developments include multiple subsidiary acquisitions and mergers to bolster operations, such as consolidated subsidiary Happy Life Ikkou acquiring Sunrise Villa Tsuchiura in July 2025, another subsidiary acquiring Site Pharmaceuticals in Inazawa City in June 2025, Kochi Daiichi Yakuhin in April 2025, Keiyo Sawai Yakuhin and discussions on Shizuoka Sawai Yakuhin in late 2024, Sato Yakuhin Hanbai and Wakamatsu Yakuhin in September 2024, and Kyoju Yakuhin in April 2024; internal reorganizations like subsidiary absorptions including Healthcare Ikkou with HAPINE lifecare and others in 2025 and 2024; pharmacy network expansions and closures for optimization; certifications of multiple Flower Pharmacy stores as regional collaboration pharmacies in 2025; upward revisions to full-year earnings forecasts and increased dividends including a 40th anniversary special in March 2025; implementation of a medium-term management plan and enhanced shareholder return policies like stock buybacks and cancellations in April 2025; and ongoing community initiatives such as health lectures and media features on topics like heatstroke prevention and medication safety. [web:web:company website]